381 results on '"Hayden, Frederick G"'
Search Results
2. Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.
3. Infectious Diseases Society of America and Gain-of-Function Experiments With Pathogens Having Pandemic Potential
4. Macrolides in critically ill patients with Middle East Respiratory Syndrome
5. Cardiac Findings during Uncomplicated Acute Influenza in Ambulatory Adults
6. Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America
7. Rhinovirus Infections in Hematopoietic Stem Cell Transplant Recipients with Pneumonia
8. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
9. Perspectives on Antiviral Use during Pandemic Influenza
10. Clinical and Economic Impact of COVID-19 on Agricultural Workers, Guatemala1
11. The Immunogenicity of Influenza Virus Vaccine in Solid Organ Transplant Recipients
12. Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia
13. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
14. Short-Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo-Controlled Study
15. Editorial Response: Rhinovirus Pneumonia: A Clinical Entity?
16. Enterovirus Meningitis in Adults
17. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
18. Emerging Influenza Antiviral Resistance Threats
19. End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life-Threatening Disease
20. "Prepandemic" Immunization for Novel Influenza Viruses, "Swine Flu" Vaccine, Guillain-Barré Syndrome, and the Detection of Rare Severe Adverse Events
21. Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals
22. Preventing the Airborne Spread of Staphylococcus aureus by Persons With the Common Cold: Effect of Surgical Scrubs, Gowns, and Masks
23. John F. Enders Lecture 2006: Antivirals for Influenza
24. Seasonal and Pandemic Influenza: Recommendations for Preparedness in the United States
25. Antiviral Management of Seasonal and Pandemic Influenza
26. "Gesundheit!" Sneezing, Common Colds, Allergies, and Staphylococcus aureus Dispersion
27. Comparative Activities of Oseltamivir and A-322278 in Immunocompetent and Immunocompromised Murine Models of Influenza Virus Infection
28. Recovery of Drug-Resistant Influenza Virus from Immunocompromised Patients: A Case Series
29. Influenza Treatment with Neuraminidase Inhibitors: Cost-Effectiveness and Cost-Utility in Healthy Adults in the United Kingdom
30. Preventing Nosocomial Influenza by Improving the Vaccine Acceptance Rate of Clinicians
31. Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment with or without Postexposure Prophylaxis
32. Efficacy and Safety of Oral Pleconaril for Treatment of Colds Due to Picornaviruses in Adults: Results of 2 Double-Blind, Randomized, Placebo-Controlled Trials
33. Assessment of Hemagglutinin Sequence Heterogeneity during Influenza Virus Transmission in Families
34. Rhinovirus and Coronavirus Infection-Associated Hospitalizations among Older Adults
35. Accumulation of Defective Neuraminidase (NA) Genes by Influenza a Viruses in the Presence of NA Inhibitors as a Marker of Reduced Dependence on NA
36. Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with Oseltamivir
37. Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine
38. Nasal Cytokine and Chemokine Responses in Experimental Influenza a Virus Infection: Results of a Placebo-Controlled Trial of Intravenous Zanamivir Treatment
39. Overview of the 3rd isirv-Antiviral Group Conference – advances in clinical management
40. Effect of Rimantadine Treatment on Clinical Manifestations and Otologic Complications in Adults Experimentally Infected with Influenza A (H1N1) Virus
41. Emergence of Drug Resistance during an Influenza Epidemic: Insights from a Mathematical Model
42. Effects of the Neuraminidase Inhibitor Zanamivir on Otologic Manifestations of Experimental Human Influenza
43. Antivirals for Pandemic Influenza
44. Prevention of Nosocomial Influenza
45. Acute encephalopathy associated with influenza A infection in adults
46. Advances in antivirals for non-influenza respiratory virus infections
47. Second isirv antiviral group conference: overview
48. Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial
49. Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
50. Global outbreak research: harmony not hegemony
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.